Deloitte finalises Recom buy
18 July, 2008 by Kate McDonaldDeloitte completes acquisition of Recombinant Capital
Virosome studied by MedImmune
18 July, 2008 by Dylan Bushell-EmblingNorwood Abbey subsidiary's technology to be evaluated by MedImmune
HalcyGen works on IND
18 July, 2008 by Dylan Bushell-EmblingHalcyGen completes recruitment for SUBA-Itraconazole trial
Mesoblast's long-term protection
16 July, 2008 by Dylan Bushell-EmblingMesoblast awarded extended patent for MPC stem cells
Fun for Avita
16 July, 2008 by Dylan Bushell-EmblingFunhaler sales up, CellSpray still on the shelf
Neuren thinks big
16 July, 2008 by Dylan Bushell-EmblingNeuren completes recruitment for Phase III trials for cognitive impairment
More interest in Biosignal
15 July, 2008 by Dylan Bushell-EmblingBiosignal's anti-corrosion treatment under evaluation from ConocoPhillips
Unitract rolls out
15 July, 2008 by Dylan Bushell-EmblingUnilife commences sales of Unitract 1mL safety syringes
Circadian swallows Vegenics
15 July, 2008 by Dylan Bushell-EmblingCircadian is to trade shares for the remaining third of Vegenics
Proteome pulls out of prostate test
15 July, 2008 by Dylan Bushell-EmblingProteome Systems abandons prostate cancer test development
Stirling fishes for trout
15 July, 2008 by Dylan Bushell-EmblingStirling presents results of Loma salmonae treatment trials
Genetic Technologies gets tough
14 July, 2008 by Kate McDonaldGTG to enforce rights to BRCA patents
Prana candidate reduces Abeta levels
10 July, 2008 by Dylan Bushell-EmblingPrana research shows PBT2 reduces Abeta and improves cognition in mouse model
Mesoblast targets AMD and retinopathy
10 July, 2008 by Dylan Bushell-EmblingMesoblast's allogeneic stem cells in trial for diabetic retinopathy and age-related macular degeneration.
Medigard selects site for trials
10 July, 2008 by Dylan Bushell-EmblingGold Coast's Medigard chooses Genomics Research Centre at Griffith Uni for trials
